{
  "thread": {
    "uuid": "1db7175f2f98f3544979d433badb5a37b320df71",
    "url": "https://news.bgov.com/litigation/novartis-fights-msns-push-to-delist-revived-entresto-patent",
    "site_full": "news.bgov.com",
    "site": "bgov.com",
    "site_section": "https://news.bgov.com/litigation",
    "site_categories": [],
    "section_title": "Litigation",
    "title": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
    "title_full": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
    "published": "2025-02-20T23:47:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://db0ip7zd23b50.cloudfront.net/dims4/default/521f1d9/2147483647/legacy_thumbnail/960x370%3E/quality/90/?url=http%3A%2F%2Fbloomberg-bna-brightspot.s3.amazonaws.com%2F72%2F46%2F480a82e746e39af2bf4fa9583055%2Fgettyimages-1647272651.jpg",
    "performance_score": 0,
    "domain_rank": 25159,
    "domain_rank_updated": "2025-02-17T23:00:00.000+02:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "1db7175f2f98f3544979d433badb5a37b320df71",
  "url": "https://news.bgov.com/litigation/novartis-fights-msns-push-to-delist-revived-entresto-patent",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "Christopher Yasiejko",
  "published": "2025-02-20T23:47:00.000+02:00",
  "title": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
  "text": "MSN’s attempt to delist US Patent No. 8,101,659 from the US Food and Drug Administration’s registry of approved drugs is legally flawed because the underlying lawsuit concerns standard patent-infringement claims rather than Hatch-Waxman allegations, the Swiss drugmaker said Wednesday in a brief supporting its motion to dismiss in the US District Court for the District of Delaware. Novartis also separately asked the court to reject MSN’s ...\nFeb. 20, 2025, 9:47 PM UTC",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Economy, Business and Finance"
  ],
  "topics": [
    "Health->drug rehabilitation",
    "Economy, Business and Finance->healthcare industry",
    "Economy, Business and Finance->business governance",
    "Economy, Business and Finance->financial service"
  ],
  "ai_allow": true,
  "has_canonical": true,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://www.bloomberglaw.com/product/blaw/document/XUE010200HGKI05GHF?criteria_id=9653ebd7dbd806fbf8eb60993073e48e&searchGuid=2029d805-78da-46f0-b43e-1238879ceaf0",
    "https://www.bloomberglaw.com/product/blaw/document/X1Q6OQ0B5K82",
    "https://www.bloomberglaw.com/public/document/InreEntrestoSacubitrilValsartanPatentLitigationDocketNo120md02930/17?doc_id=X5HMQORIIP18UDRDRGMA6259ORR",
    "https://www.bloomberglaw.com/public/document/InreEntrestoSacubitrilValsartanPatentLitigationDocketNo120md02930/17",
    "https://bloomberglaw.com/product/blaw/document/XUE010200HGKI05GHF?criteria_id=9653ebd7dbd806fbf8eb60993073e48e&searchGuid=2029d805-78da-46f0-b43e-1238879ceaf0",
    "https://bloomberglaw.com/public/document/InreEntrestoSacubitrilValsartanPatentLitigationDocketNo120md02930/17?doc_id=X5HMQORIIP18UDRDRGMA6259ORR",
    "https://bloomberglaw.com/product/blaw/document/X1Q6OQ0B5K82",
    "https://www.bloomberglaw.com/product/blaw/document/XUE010200HGKI05GHF"
  ],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": null,
  "rating": null,
  "crawled": "2025-02-21T00:05:56.165+02:00",
  "updated": "2025-02-21T00:05:56.165+02:00"
}